Dendritic cell-based immunotherapy for cancer reviewed.

2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Researchers review dendritic cell-based immunotherapy for cancer in a recent issue of Transfusion Medicine Reviews.

According to recent research from the United States, "The encouraging results from dendritic cell-related cancer immunotherapy have created tremendous interest for its broad clinical application. Dendritic cells are the most potent antigen-presenting cells. In cancer patients, dendritic cell production and function along with other antitumor immune defenses are compromised."

"Autologous dendritic cells enriched and sensitized in vitro with tumor-associated antigens can effectively elicit host cellular …